Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Illmer

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Cancer Treatment Reviews|May 26, 2009
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic reviewChristoph Röllig, Thomas Illmer
Leukemia & Lymphoma|October 23, 2002
Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemiaMarkus Schaich, Thomas Illmer
Clinical Lymphoma & Myeloma|March 8, 2008
FLT3 kinase inhibitors in the management of acute myeloid leukemiaThomas Illmer, Gerhard Ehninger
Journal of Virological Methods|September 8, 2006
Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCRJulian Sassenscheidt, Jacques Rohayem, Thomas Illmer, et al.
Haematologica|January 19, 2007
Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemiasThomas Illmer, Markus Schaich, Gerhard Ehninger, et al.
British Journal of Haematology|January 26, 2005
MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemiaMarkus Schaich, Silke Soucek, Christian Thiede, et al.
British Journal of Haematology|May 15, 2004
A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosisMarkus Schaich, Rainer Koch, Silke Soucek, et al.
Blood|June 21, 2011
MicroRNA29a regulates the expression of the nuclear oncogene SkiSabine Teichler, Thomas Illmer, Josephine Roemhild, et al.
Blood|February 4, 2006
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)Christian Thiede, Sina Koch, Eva Creutzig, et al.
Mycoses|March 27, 2010
Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemiaThomas Illmer, Jana Babatz, Stefan Pursche, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Cancer Treatment Reviews|May 26, 2009
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic reviewChristoph Röllig, Thomas Illmer
Leukemia & Lymphoma|October 23, 2002
Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemiaMarkus Schaich, Thomas Illmer
Clinical Lymphoma & Myeloma|March 8, 2008
FLT3 kinase inhibitors in the management of acute myeloid leukemiaThomas Illmer, Gerhard Ehninger
Journal of Virological Methods|September 8, 2006
Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCRJulian Sassenscheidt, Jacques Rohayem, Thomas Illmer, et al.
Haematologica|January 19, 2007
Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemiasThomas Illmer, Markus Schaich, Gerhard Ehninger, et al.
British Journal of Haematology|January 26, 2005
MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemiaMarkus Schaich, Silke Soucek, Christian Thiede, et al.
British Journal of Haematology|May 15, 2004
A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosisMarkus Schaich, Rainer Koch, Silke Soucek, et al.
Blood|June 21, 2011
MicroRNA29a regulates the expression of the nuclear oncogene SkiSabine Teichler, Thomas Illmer, Josephine Roemhild, et al.
Blood|February 4, 2006
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)Christian Thiede, Sina Koch, Eva Creutzig, et al.
Mycoses|March 27, 2010
Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemiaThomas Illmer, Jana Babatz, Stefan Pursche, et al.
Pageof 8